Results 231 to 240 of about 6,125,058 (320)

Full Issue, Volume 5, Number 3

open access: yesJournal of Human Sciences and Extension, 2017
Journal of Human Sciences and Extension
doaj  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Multi-joint isokinetic strength profiling as a predictor of vertical jump performance in elite freestyle wrestlers: A cross-sectional principal component analysis. [PDF]

open access: yesMedicine (Baltimore)
Sever O   +9 more
europepmc   +1 more source

Canine hip extension range during gait

open access: gold, 2008
A.M. van der Walt   +3 more
openalex   +2 more sources

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy